EGFR-labeled and GPC3-targeted Autologous T cells(Nanjing Drum Tower Hospital)

EGFR肽段标记的靶向GPC3嵌合抗原受体T细胞（南京鼓楼医院）

Report date: 2026/05/21 20:00:22

Base Information

Drug NameEGFR-labeled and GPC3-targeted Autologous T cells(Nanjing Drum Tower Hospital)
Drug Alias NameEGFR-labeled CAR-GPC3 T-cellEGFR标记GPC3靶向CAR-T(南京鼓楼医院)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyCell and gene therapy > Cell therapy > Donor > Autologous
Mechanisms of ActionGlypican-3 modulators
TargetsGlypican-3
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesNanjing Drum Tower Hospital
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Drum Tower Hospital
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A